Functioning of Elder Muscle; Understanding Recovery
Launched by UNIVERSITY OF NOTTINGHAM · Feb 19, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Functioning of Elder Muscle; Understanding Recovery," is studying how the muscles of older adults with frailty work, especially after they have suffered a hip fracture. As people age, they often lose muscle mass, which can lead to a higher risk of falls and slower recovery from injuries or surgeries. The researchers want to understand not just how much muscle someone has, but also how well that muscle functions and what it contains, like fats and proteins. They will also explore if the muscle’s health affects how well a person recovers after a hip fracture.
To be eligible for this study, participants need to be older adults who have a Clinical Frailty Score of 4 or higher, have sustained a hip fracture from a fall that requires surgery, and can understand and communicate in English. Participants can expect to undergo assessments that help researchers measure their muscle function and overall health. It’s important to know that certain individuals, such as those with specific medical conditions or who have fallen more than 12 hours before being hospitalized, will not be included in this study. This trial aims to improve our understanding of muscle health in older adults and how it affects recovery from injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical Frailty Score (assessed as part of standard care) ≥ 4
- • Fractured hip, sustained following a fall, that requires surgery
- • Good understanding of spoken and written English language
- • Able to give informed consent, or availability of a legally acceptable surrogate to provide consent
- Exclusion Criteria:
- • Those who fell and sustained their hip fracture greater than 12 hours prior to hospitalisation.
- • Those who have fallen and sustained a hip fracture whilst an in-patient in hospital
- • Those who sustained the hip fracture as a result of high impact trauma (e.g. road traffic accident)
- • Surgery carried out later than 96 hrs after fall
- • Chronic neurological, inflammatory or musculoskeletal disorders which result in muscle wasting, e.g. Multiple sclerosis, muscular dystrophy, rheumatoid arthritis
- • Any co-morbidity which precludes hip surgery
- • Those with a compromised swallowing reflex which would prevent the participant from taking fluids orally, will be excluded.
- • Those taking diabetes medication
About University Of Nottingham
The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, , United Kingdom
Patients applied
Trial Officials
Ben Ollivere, MBBS
Principal Investigator
University of Nottingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials